Cambridge, MA · Founded 2013 · Privately Held (backing)
Developer of a neuroscience research platform designed to accelerate the discovery of therapeutics for central nervous system disorders. Quiver Bioscience is based in Cambridge, MA and was founded in 2013. Its last reported valuation was $29 million in Nov 2018. It has raised $54.4 million.
Last reported valuation
$29.0M
Oct 2026
Priced at
—
Total raised
$54.4M
Last round
—
Cap table — not yet on record
Quiver Bioscience's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Quiver Bioscience with a free account
·Watch Quiver Bioscience: the Monday email on marks, rounds and moves
